Metagenome-Assembled Genomes (MAGs) Services Global Market Report 2026

The metagenome-assembled genomes (MAGs) services market size has grown rapidly in recent years. It will grow from $1.38 billion in 2025 to $1.6 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to advancements in next-generation sequencing technologies, growth in microbiome research initiatives, increasing availability of high-throughput sequencing platforms, rising academic funding for environmental microbiology, expansion of bioinformatics expertise and infrastructure.

The metagenome-assembled genomes (MAGs) services market size is expected to see rapid growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to growing demand for precision microbiome-based therapeutics, increasing adoption of AI-driven genome reconstruction tools, rising application in agricultural microbiome optimization, expansion of cloud-based bioinformatics services, increasing focus on uncultured microbial diversity exploration. Major trends in the forecast period include increasing adoption of hybrid genome assembly approaches, rising demand for high-quality metagenome binning services, growing use of long-read sequencing for complex microbiomes, expansion of functional and comparative genomics annotation, rising integration of end-to-end custom bioinformatics pipelines.

The rising prevalence of infectious diseases is expected to drive the growth of the metagenome assembled genomes (MAGs) services market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, which can spread directly or indirectly among people or through the environment. The prevalence of infectious diseases is increasing due to urbanization, which elevates population density and close human contact, facilitating pathogen transmission. Metagenome assembled genomes (MAGs) services aid in studying and managing infectious diseases by reconstructing complete microbial genomes from complex environmental or clinical samples, allowing researchers to identify pathogens, track outbreaks, and understand microbial diversity and resistance mechanisms accurately and promptly. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Therefore, the rising prevalence of infectious diseases is driving the growth of the metagenome assembled genomes (MAGs) services market.

Key companies operating in the metagenome-assembled genomes (MAGs) services market are focusing on developing innovative solutions, such as high-resolution long-read sequencing platforms to improve accuracy and completeness in microbial genome reconstruction. High-resolution long-read sequencing platforms are technologies that generate extended DNA reads with high accuracy, helping researchers capture complete microbial genomes and resolve complex regions that short-read methods often miss, improving genome assembly and microbial profiling in a single workflow. For example, in April 2024, Clinical Microbiomics A/S, a Denmark-based microbiome-focused biotechnology company, launched its advanced long-read 16S, ITS, 18S isolate, and metagenomics sequencing services, offering a comprehensive platform for microbial identification and functional analysis. The platforms combine optimized sample preparation, high-fidelity long-read sequencing, and robust bioinformatics pipelines to reconstruct complete metagenome-assembled genomes, providing precise insights into microbial diversity and function. They enable researchers to explore complex environmental, clinical, and gut microbiomes with enhanced resolution, support high-throughput studies, and reduce ambiguity in genome assembly compared to conventional approaches. These services are particularly beneficial for applications in microbiome research, clinical diagnostics, and biotechnology development.

In March 2024, Clinical Microbiomics A/S, a Denmark-based healthcare technology company, acquired DNASense ApS for an undisclosed amount. Through this acquisition, Clinical Microbiomics aimed to advance its technological capabilities by integrating long-read DNA and RNA sequencing, thereby expanding services across human, animal, and environmental microbiome applications. DNASense ApS is a Denmark-based healthcare technology company specializing in metagenome-assembled genomes (MAGs) services.

Major companies operating in the metagenome-assembled genomes (MAGs) services market are Thermo Fisher Scientific Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., Seven Bridges Genomics Inc., DNAnexus Inc., Lifebit Biotech Ltd., Eurofins Genomics Germany GmbH, Zymo Research Corp., CD Genomics Inc., BaseClear B.V., QIAGEN Digital Insights GmbH, Eagle Genomics Ltd., Creative Biogene Inc., MR DNA LLC, Microba Life Sciences Pty Ltd, CosmosID Inc., One Codex Inc.

North America was the largest region in the metagenome-assembled genomes (MAGs) services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenome-assembled genomes (MAGs) services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metagenome-assembled genomes (MAGs) services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metagenome-assembled genomes (MAGs) services market includes revenues earned by entities by providing services such as sequencing services, bioinformatics analysis, cloud-based data processing, consulting, and customized microbial genome reconstruction solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metagenome-assembled genomes (MAGs) services are specialized bioinformatics and sequencing offerings that reconstruct individual microbial genomes directly from metagenomic datasets derived from complex environmental or clinical samples. These services include DNA sequencing, data quality assessment, genome assembly, binning, and annotation to produce draft or nearly complete genomes of uncultured microorganisms, allowing functional analysis, ecological profiling, and identification of microbial community members without requiring lab cultivation.

The key service types of metagenome-assembled genomes (MAGs) services include genome assembly, genome annotation, data analysis, custom bioinformatics, and other offerings. Genome assembly refers to computational processes that reconstruct complete genomes from fragmented sequencing data to enable downstream analysis. Technologies utilized include next-generation sequencing (NGS), third-generation sequencing (long-read sequencing), cloud-based bioinformatics platforms, and artificial intelligence (AI) and machine learning-based analytics. Applications span environmental microbiology, clinical diagnostics, agricultural research, biotechnology, and other areas, serving academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other end-users.

Tariffs on imported sequencing instruments, reagents, and high-performance computing hardware are impacting the MAGs services market by increasing operational and project costs, particularly affecting genome assembly and data analysis service segments. Regions reliant on global supply chains for advanced sequencing platforms, including North America and Europe, are most affected. Higher equipment and reagent costs may constrain research budgets in academic and biotechnology sectors; however, tariffs are also encouraging local sequencing infrastructure development, regional bioinformatics capacity building, and diversified supplier networks, strengthening long-term service resilience.

The metagenome-assembled genomes (MAGs) services market research report is one of a series of new reports that provides metagenome-assembled genomes (MAGs) services market statistics, including metagenome-assembled genomes (MAGs) services industry global market size, regional shares, competitors with a metagenome-assembled genomes (MAGs) services market share, detailed metagenome-assembled genomes (MAGs) services market segments, market trends and opportunities, and any further data you may need to thrive in the metagenome-assembled genomes (MAGs) services industry. This metagenome-assembled genomes (MAGs) services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.